Sleep in children with cancer

Current Opinion in Pediatrics

Volumn 20, Issue 6, 2008, Pages 676-681

  Rosen, Gerald M ^a,d   Shor, Audrey C ^b   Geller, Thomas J ^c  

^a Minnesota Regional Sleep Disorder Center   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

Author keywords

Brain tumors; Childhood cancer; Excessive daytime sleepiness; Hypothalamic injury; Sleep disorders

Indexed keywords

BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVOR; CHILDHOOD CANCER; CIRCADIAN RHYTHM; DAYTIME SOMNOLENCE; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SLEEP DISORDER;

BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHRONOBIOLOGY DISORDERS; HUMANS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SLEEP DISORDERS;

EID: 57149120132     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328312c7ad     Document Type: Review

References (45)

1. Saper C, Scammell T, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005; 437:1257-1263.
2. Rosen GM. Sleep in children with cancer. Sleep Biol Rhythms 2007; 5:A73. This is the largest case series (56 cases) of objectively evaluated sleep problems in children with cancer, utilizing polysomnography, multiple sleep latency test and actigraphy, as well as clinical evaluations. This has been published in abstract form only.
3. Muller H, Handwerker G, Gebhardt U, et al. Melatonin treatment in obese patients with craniopharyngioma and increased sleepiness. Cancer Causes Control 2007; 17:583-589. This article describes the association of sleepiness, obesity, and salivary melatonin in a large case series of adult survivors of childhood craniopharyngiomas (79 patients) and hypothalamic pilocytic astrocytomas (19 patients) and controls. The patients with either tumor who were morbidly obese, BMI more than 4 SD, had lower salivary melatonin levels, and their EDS improved with nocturnal treatment of melatonin administration.
4. Puget S, Garnett M, Wray A, et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg: Pediatrics 2007; 106:3-12. This study evaluated the preoperative MRI and the postoperative outcome of 66 children treated surgically for a craniopharyngioma and used the data to develop a preoperative classification system to grade hypothalamic involvement and thereby stratify the surgical treatment recommendations. Patients with hypothalamic involvement were treated with subtotal or partial resections instead of gross total resections, minimzing the surgical morbidity.
5. Benesch M, Lackner H, Sovinz P, et al. Late sequela after treatment of childhood low-grade gliomas: a retrospective analysis of 69 long term survivors treated between 1983 and 2003. J Neurooncol 2006; 78:199-205.
6. Miller AH, Ancoli-Israel S, Bower JE, et al. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 2008; 26:971-982. This paper reviews the literature of the neuro-endocrine and immune mechanisms of patients with cancer and behavioral problems, and proposes possible ways that these two comorbidities may be interrelated.
7. Wilne S, Collier J, Kennedy C, et al. Presentation of childhood CNS tumours: a systematic review and meta-analysis. Lancet Oncol 2007; 8:685-695. This article provides a meta-analysis of the published literature on the presenting symptoms of children with brain tumors reported between 1991-2005, from 71 papers involving 4171 children.
8. Levi F. Chronotherapeutics: the relevance of timing in cancer therapy. Cancer Causes Control 2006; 17:611-621.
9. Someren E, Swart-Heikens J, Endert E, et al. Long term effect of cranial irradiation for childhood malignancy on sleep in adulthood. European J Endo 2004; 150:503-510.
10. Rosen GM. Sleep in children who have cancer. Sleep Med Clin 2007; 2:491-500. This article summarizes the important physiologic processes important in the regulation of sleep, especially as they relate to children with cancer.
11. Hinds P, Hockenberry M, Gattuso J, et al. Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. Cancer 2007; 110:2321-2330. This study uses actigraphy to objectively quantify the adverse effect of high-dose dexamethasone on sleep in children with acute lymphoblastic leukemia. Dexamethasone leads to an increase in total sleep time, increased number of awakenings from sleep, increase in daytime sleep, and increased daytime fatigue.
12. Gregory A, Rijsdik F, Dahl R, et al. Associations between sleep problems, anxiety, and depression in twins at 8 years of age. Pediatrics 2006; 118:1124-1132.
13. Alfano C, Beidel D, Turner S, et al. Preliminary evidence for sleep complaints among children referred for anxiety. Sleep Med 2006; 7:467-473.
14. Kazak A, Kassam-Adams N, Schneider S, et al. An integrative model of pediatric medical traumatic stress. J Pediatr Psychol 2006; 31:343-355.
15. Langeveld N, Grootenhuis M, Voute P, et al. Posttraumatic stress symptoms in adult survivors of childhood cancer. Pediatr Blood Cancer 2004; 42:604-610.
16. Mindell J, Owens J. A clinical guide to pediatric sleep, diagnosis and management of sleep problems. Philadelphia: Lippincott; 2003.
17. Jenni OG, Carscadon MA. Sleep behavior and sleep regulation from infancy through adolescence: normative aspects. Sleep Med Clin 2007; 2:321-329. An excellent review of basic sleep physiology with a focus on the homeostatic and circadian control of sleep, including an extensive discussion of the normative data on sleep in children.
18. Borbely AA, Achermann P. Sleep homeostasis and models of sleep regulation. J Biol Rhythms 1999; 14:559-568.
19. Lamont EW, James FO, Boivin DB, et al. From circadian clock gene expression to pathologies. Sleep Med 2007; 8:547-556. This article summarizes the current understanding of the human clock genes and their expression. Clock gene defects are responsible for the circadian rhythm disorders of advanced and delayed sleep phase syndromes, and are likely to be found to be important in many other diseases including cancers. This is a special issue of Sleep Medicine, which is devoted to various facets of circadian rhythm research.
20. Cancer Facts and Figures 2007. http://www.cancer.org/downloads/STT/ CAFF2007PWSecured.pdf.
21. Central CBTRUS (2005). Statistical Report: Primary Brain Tumors in the United States, 1998-2002. Published by the Central Brain Tumor Registry of the United States.
22. Mulhern RK, Merchant TE, Wallace D, et al. Neurocognitive consequences of risk adapted therapy for childhood medulloblastoma. J Clin Oncol 2005; 23:5511-5519.
23. Duffner PK. The long term effects of chemotherapy on the central nervous system. J Biol 2006; 5:21-26.
24. Song Y, Smaulski T, Van Dyke T. Cancer: a conceptual framework. In: DeVita V, Lawrence T, Rosenberg S, editors. Cancer Principles & Practices of Oncology, 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. pp. 3-12.
25. Weinberg RA. The Nature of Cancer. In: The Biology of Cancer. New York: Garland Science, Taylor & Francis Group, LLC; 2007. pp. 25-56.
26. Reis L, Eisner M, Kosary C, et al. SEER cancer statistics review, 1975-2002. Bethesda, MD: National Cancer Institute; 2005.
27. Packer R, MacDonald T, Vezina G. Central nervous system tumors. Pediatr Clin N Am 2008; 55:121-145. This article reviews the relative incidences, clinical presentations, biological predictors and appropriate diagnosis/current therapies of CNS tumors in childhood.
28. Anderson NE. Late complications in childhood CNS tumors. Curr Opin Neurol 2003; 16:677-683.
29. Gurney JG, Kadan-Lottick NS, Packer RJ, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors. Childhood Cancer Survivor Study. Cancer 2003; 97:663-673.
30. Teicher BA. Newer cytotoxic agents: attacking cancer broadly. Clin Cancer Res 2008; 14:1610-1617.
31. Robertson PL. Advances in treatment of pediatric brain tumors. NeuroRx 2006; 3:276-291.
32. Revard G, Hoyoux C, Infante-Rivard C, et al. Maintenance chemotherapy for childhood lymphoblastic leukemia: better in the evening. Lancet 1985; 2:1264-1266.
33. Giacchetti S, Bjarnason G, Garufi C, et al. First line infusion of 5-fluorouracil, leucovorin, and oxaliplatin for metastatic colorectal cancer: 4-day chronomodulated versus 2-day FOLFOX2. A multicenter randomized phase III trial of the chronotherapy group of the Europeanorganization for research and treatment of cancer (EORTC05963). Proc Am Soc Clin Oncol 2004; 23:731.
34. Stevens RG. Artificial lighting in the industrialized world: circadian disruption and breast cancer. Cancer Causes Control 2006; 17:501-507.
35. Filipski E, Li XM, Levi F. Disruption of circadian coordination and malignant growth. Cancer Causes Control 2006; 17:509-514.
36. Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 2005; 9:269-310.
37. Laughton SJ, Merchant TE, Sklar CA, et al. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary site radiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol 2008; 1:1112-1118.
38. Morgenthaler TI, Kapur VK, Brown TM, et al. Practice parameters for the treatment of narcolepsy and other hypersomnia of central origin. Sleep 2007; 12:1705-1711. This article reviews the literature of EDS and provides recommendations for treatment from the standards of practice committee of the academy of sleep medicine.
39. Meeske K, Katz ER, Burwinkle T, et al. Parent proxy-reported health related quality of life and fatigue in pédiatrie patients diagnosed with brain tumors and acute lymphoblastic leukemia. Cancer 2004; 101:2116-2125.
40. Miser A, McCalla J, Dothage J, et al. Pain as a presenting symptom in children and young adults with newly diagnosed malignancy. Pain 1987; 29:85-90.
41. Ljungman G, Gordh T, Sorensen S, et al. Pain variations during cancer treatment in children: a descriptive study. Pediatr Hematol Oncol 2000; 17:211-221.
42. Smith M, Edwards R, McCann U, et al. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 2007; 30:494-505.
43. Hinds PS, Hockenberry M, Rai SN, et al. Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer. Oncol Nurs Forum 2007; 34:393-402.
44. American Academy of Sleep Medicine. International classification of sleep disorders. 2nd ed. Posttraumatic stress disorder. Diagnostic and coding manual: 261-262. Westchester, Illinois: American Academy of Sleep Medicine; 2005.
45. Rosen G. Evaluation of the patient who has sleep complaints: a case based method using the sleep process matrix. Prim Care Clin Office Pract 2005; 32:319-328.